2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

ASCO 2020 Update on ctDNA & MRD Testing in mCRPC: What Is Prognostic Value of Plasma cfDNA Useful in GMB Patients? What Are the Limitations?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Gregory Botta
By 2020 ASCO Virtual Direct™ Highlights FEATURING Gregory Botta
8 views
February 11, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

20:59
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam
Basic Science
14:05
2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Update on ctDNA Testing: What Are the Clinical Uses of ctD…

Feat. G. Botta
05:43
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on cfDNA Analysis Among Carcinoma of Unknown Primar…

Feat. G. Botta
08:38
2020 ASCO Virtual Direct™ Highlights

ASCO 2020 Update on ctDNA & MRD Testing in mCRPC: What Is Progno…

Feat. G. Botta
10:05
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on ctDNA and MRD Testing: What Is the Post-Therapy …

Feat. G. Botta